Invention Grant
US08663937B2 Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
有权
用于24-羟基化维生素D化合物的克隆跨膜受体及其用途
- Patent Title: Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
- Patent Title (中): 用于24-羟基化维生素D化合物的克隆跨膜受体及其用途
-
Application No.: US13906014Application Date: 2013-05-30
-
Publication No.: US08663937B2Publication Date: 2014-03-04
- Inventor: Rene St-Arnaud
- Applicant: Shriners Hospital For Children
- Applicant Address: US FL Tampa
- Assignee: Shriners Hospital For Children
- Current Assignee: Shriners Hospital For Children
- Current Assignee Address: US FL Tampa
- Agency: Baker Botts LLP
- Main IPC: G01N33/53
- IPC: G01N33/53 ; C12Q1/68 ; G01N33/567
Abstract:
The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
Public/Granted literature
- US20130252252A1 CLONED TRANSMEMBRANE RECEPTOR FOR 24-HYDROXYLATED VITAMIN D COMPOUNDS AND USES THEREOF Public/Granted day:2013-09-26
Information query
IPC分类:
